Reaction profile

The FDA adverse-event record for eye numbness

Name: Eye numbness - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

15 FDA reports name eye numbness, a lower-volume reaction in the CVM extract (VeDDRA 1235). Plate stamps and neighbourhood peers follow.

#2299 of 2,481
by report volume (all reactions): 15
reports citing this reaction: 0.0%
death-coded share: Human
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Eye numbness has 15 reports now versus 15 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Eye numbness changes

FDA AER · VeDDRA plate

Code 1235 VOL-TRACE

VOL-TRACE · DEATH-RARE · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-HUMAN · DRUG-LEAD · DESK-NARROW · BOOK-FULL

VOL-TRACE 15 reports
DEATH-RARE 0.0%
BOTTOM-DECILE #2299/2481
PHOTO-FINISH Abomasal ulcer
SPECIES-HUMAN Human · 15
DRUG-LEAD Bupivacaine Lipso… · 3
DESK-NARROW 1 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Abomasal ulcer (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Eye numbness

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Eye numbness

Eye numbness: low death-coded share in the FDA AER plate

Signature read: 15 reports place Eye numbness in the lower third of FDA AER volume (#2299 of 2,481). Report volume is lower-third scale: 15 named reports in the openFDA extract. Death-coded share is lower-third: 0 of 15 reports (0.0% of named reports). Nearest volume peer: Abomasal ulcer (±0 reports). Lead species Human (15). Lead co-reported drug Bupivacaine Lipsome Injectable Suspension (3).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Bupivacaine Lipsome Injectable Suspension appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Human 15

Breeds Most Affected

Unknown 15

Associated Drugs

Bupivacaine Lipsome Injectable Suspension 3

Tresaderm Dermatological Solution 2

Selamectin;Sarolaner 2

Carprofen 1

Melarsomine Dihydrochloride Injection 1

Enrofloxacin + Silver Sulfadiazine 1

Dexmedetomidine Hydrochloride 1

Imidacloprid + Moxidectin 1

Tylosin Tartrate 1

Diphenhydramine 1

Analgesic (Unknown) 1

Bupivacaine 1

Bupivacaine Liposome 1

Sodium Chloride 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Eye numbness (#2299 of 2,481 by report volume); death-coded 0.0%. PlainBreed reaction plate · report volume stamp 15 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →